EUCTR2010-021435-14-NL进行中（未招募）不适用
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis
Academisch Medisch Centrum Amsterdam0 个研究点开始时间: 2010年6月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Males and females with a diagnosis of active rheumatoid arthritis (with a DAS28 CRP > 3,2) who have failed MTX therapy, with an inflamed knee, ankle or wrist joint.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Breastfeeding
- •Subjects who are impaired, incapacitated, or incapable of completing study
- •related assessments.
- •Subjects who meet diagnostic criteria for any other rheumatic disease (e.g., lupus
- •erythematous).
- •Subjects who have previously received treatment with an investigational biologic RA therapy, anti-TNF therapy, rituximab, tocilizumab or abatacept.
研究者
相似试验
尚未招募
4 期
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis10003816rheumatoid arthritisNL-OMON34549Academisch Medisch Centrum16
招募中
不适用
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis.RAReumatoide ArtritisRheumatoid ArthritisReumaNL-OMON22398AMC Amsterdam16
已完成
不适用
ong-Term Outocomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settingsrheumatoid arthritisJPRN-UMIN000021263Bristol-Myers Squibb K.K. Ono Pharmaceutical CO.,LTD.325
已完成
2 期
A pilot study examining the effect of abatacept in ANCA associated vasculitis (AAV)Wegener granulomatosisANCA Associated Vasculitis (AAV)100038161002321310047066NL-OMON31540Academisch Medisch Centrum4
已完成
1 期
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers SquibbRheumatoid ArthritisNCT01439204Bristol-Myers Squibb223